We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$18.9B
AUM Growth
-$506M
Cap. Flow
-$125M
Cap. Flow %
-0.66%
Top 10 Hldgs %
32.49%
Holding
349
New
7
Increased
85
Reduced
184
Closed
13

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$155M
2
MSFT icon
Microsoft
MSFT
+$59.9M
3
APO icon
Apollo Global Management
APO
+$36.2M
4
TSM icon
TSMC
TSM
+$30.3M
5
ORCL icon
Oracle
ORCL
+$27.8M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$117M
2
SBUX icon
Starbucks
SBUX
+$106M
3
CDW icon
CDW
CDW
+$49.2M
4
NXPI icon
NXP Semiconductors
NXPI
+$45.6M
5
USB icon
US Bancorp
USB
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 24.21%
2 Financials 15.27%
3 Healthcare 13.36%
4 Industrials 10.95%
5 Consumer Staples 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPC icon
251
Marathon Petroleum
MPC
$83.7B
$833K ﹤0.01%
5,974
-450
-7% -$68.7K
T icon
252
AT&T
T
$163B
$832K ﹤0.01%
36,552
-2,157
-6% -$48.5K
IEMG icon
253
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$821K ﹤0.01%
15,715
-867
-5% -$48K
POOL icon
254
Pool Corp
POOL
$7.5B
$771K ﹤0.01%
2,262
STZ icon
255
Constellation Brands
STZ
$23.2B
$761K ﹤0.01%
3,443
-103
-3% -$24.5K
NOW icon
256
ServiceNow
NOW
$129B
$758K ﹤0.01%
3,575
KRP icon
257
Kimbell Royalty Partners
KRP
$1.48B
$751K ﹤0.01%
46,300
+300
+0.7% +$4.81K
CVS icon
258
CVS Health
CVS
$122B
$738K ﹤0.01%
16,451
-278
-2% -$15.6K
DHR icon
259
Danaher
DHR
$144B
$703K ﹤0.01%
3,061
+357
+13% +$87.7K
BF.B icon
260
Brown-Forman Class B
BF.B
$13.1B
$703K ﹤0.01%
18,500
-1,000
-5% -$44K
ZBH icon
261
Zimmer Biomet
ZBH
$18.4B
$692K ﹤0.01%
6,548
ESQ icon
262
Esquire Financial Holdings
ESQ
$1.14B
$684K ﹤0.01%
8,600
ALC icon
263
Alcon
ALC
$35B
$682K ﹤0.01%
8,036
+7
+0.1% +$631
MS icon
264
Morgan Stanley
MS
$340B
$671K ﹤0.01%
5,340
-60
-1% -$7.39K
TSLA icon
265
Tesla
TSLA
$1.3T
$668K ﹤0.01%
1,655
-1,077
-39% -$347K
NEM icon
266
Newmont
NEM
$119B
$643K ﹤0.01%
17,275
-1,200
-6% -$54.7K
FHN icon
267
First Horizon
FHN
$12.1B
$636K ﹤0.01%
31,577
SYY icon
268
Sysco
SYY
$40.3B
$635K ﹤0.01%
8,310
+500
+6% +$38.3K
OGS icon
269
ONE Gas
OGS
$5.04B
$631K ﹤0.01%
9,111
+58
+0.6% +$4.23K
ES icon
270
Eversource Energy
ES
$27.2B
$607K ﹤0.01%
10,572
-2,438
-19% -$152K
NFLX icon
271
Netflix
NFLX
$309B
$593K ﹤0.01%
6,650
+30
+0.5% +$2.47K
SSD icon
272
Simpson Manufacturing
SSD
$8.16B
$589K ﹤0.01%
3,549
CHRW icon
273
C.H. Robinson
CHRW
$17.5B
$586K ﹤0.01%
5,670
SAP icon
274
SAP
SAP
$238B
$579K ﹤0.01%
2,350
COR icon
275
Cencora
COR
$61.2B
$572K ﹤0.01%
2,544

Similar funds

Bahl & Gaynor's Q4 2024 Portfolio in Review

As of Q4 2024, Bahl & Gaynor held 349 positions worth $18.9B, down 2.6% from $19.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q4 2024 filing shows 7 new, 85 increased, 184 reduced and 13 closed positions. Its largest new stake was DT Midstream: 215,978 shares worth $21.5M. The largest sale was Broadcom, an estimated $117M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2024 buy was DT Midstream: 215,978 shares worth $21.5M.
  • Bahl & Gaynor added most to Johnson & Johnson in Q4 2024, an estimated $155M increase.
  • Bahl & Gaynor's biggest Q4 2024 reduction was Broadcom, cutting an estimated $117M.
  • Bahl & Gaynor fully exited Sonoco in Q4 2024, selling an estimated $8.34M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $18.9B portfolio in Q4 2024.
  • Bahl & Gaynor opened 7 new positions and closed 13 in Q4 2024.
  • Bahl & Gaynor's portfolio value fell 2.6% quarter-over-quarter to $18.9B.

Based on Bahl & Gaynor's 13F filing for Q4 2024, filed 6 Feb 2025.